Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, India. - Wikidata - wikimedia - TriplyDB

Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, India.

Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, India.

http://www.wikidata.org/entity/Q36005917

about

Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study The R enantiomer of the antitubercular drug PA-824 as a potential oral treatment for visceral Leishmaniasis.Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.PKDL--A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India.Post kala-azar dermal leishmaniasis: an unresolved mystery A male preponderance in patients with Indian post kala-azar dermal leishmaniasis is associated with increased circulating levels of testosterone.Wnt5a Signaling Promotes Host Defense against Leishmania donovani Infection.Post-kala-Azar dermal leishmaniasis: A diagnostic dilemma in a nonendemic area.

P2860

Q28543060-D07135A3-B3B3-4D98-AD5E-86F643E712EA Q28552931-7D810534-F37D-42E8-83FA-FA2A80EA8B3F Q30447200-EFEB5497-A1F2-4FD7-BABC-FE4EA621A989 Q35083527-8FA409D7-965B-4A7E-9A85-ED3A10EFAE8E Q35814962-6824AC9E-2EA7-44AA-96A2-8E24961D5702 Q35822187-BA820D83-0074-4414-8519-4E6E50F5B0B2 Q36094815-144F8847-EDDE-4AFF-B31E-F92768797D0E Q36224222-62ADEBBD-2476-484B-9487-C663F0F2B64B Q38175646-2ECA684B-294E-4D26-A48D-BA7355F16644 Q39279491-EAE09B32-7058-43B3-83CB-86D25899684F Q40154462-F34EE7FE-C4FB-467D-8D60-0C831E94D32F Q42183478-A1AB61C3-249B-4399-8D1F-499FA1547EAC

P2860

Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, India.

http://www.wikidata.org/entity/Q36005917

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Clinical epidemiologic profile ...... asis patients in Bihar, India.

@ast

Clinical epidemiologic profile ...... asis patients in Bihar, India.

@en

type

label

Clinical epidemiologic profile ...... asis patients in Bihar, India.

@ast

Clinical epidemiologic profile ...... asis patients in Bihar, India.

@en

prefLabel

Clinical epidemiologic profile ...... asis patients in Bihar, India.

@ast

Clinical epidemiologic profile ...... asis patients in Bihar, India.

@en

P1433

Q36005917-DF00EE19-7830-4DBC-BAB6-487834DFD487

P1476

Q36005917-B2C67904-EFDF-4E0C-A920-8C06680660DD

P2093

Q36005917-0A5D93F5-EC89-43C6-A190-742D0C9F2877

Q36005917-0B7AEC90-72CA-46FB-A805-73FC837592D2

Q36005917-0C48D52B-D6C5-45E1-960D-16FFA63CA14A

Q36005917-26B3EC59-A970-4C43-B643-4911E9000541

Q36005917-2DAB9D29-2B9D-45A2-BA90-2125969CB80B

Q36005917-439A77F8-33C9-473D-BE2F-998651BE2FB7

Q36005917-8D748D67-7D60-4A4A-AD3D-5AD57796406F

Q36005917-8F11F843-1CE5-48A6-B58F-4B964928306B

Q36005917-B1BC7599-D411-4BA4-8AC5-8C51BF9DF861

Q36005917-BC380797-3128-4F58-AEC5-8EE030F022BF

P2860

Q36005917-510158B8-91FC-4DD2-B9A9-436EECDE124C

Q36005917-54197BF0-C756-4094-8E18-A0F33DA7E59A

Q36005917-7F3F6F32-F77C-4C57-822A-3009D4016C55

Q36005917-888AE23F-1AF0-4D9E-9FDE-FF92FF14EC6F

Q36005917-B6AB29E2-7C24-444E-9465-6A488848CAFB

Q36005917-BD1C4FC7-6933-4711-AA99-8CCECA84ACAE

Q36005917-BE0769D2-FA44-4636-85DB-451F75F79F3A

Q36005917-C9725E33-881E-4394-BE8D-4571F03A4F0F

Q36005917-F9D3E557-4D20-44C5-8B11-3944CB51D72A

P304

Q36005917-FDE776A6-78D0-44A1-8BDC-A6B3A3DCAF9B

P31

Q36005917-B2B19BC4-D7AF-49E9-87F6-60A70F4F3039

P356

Q36005917-299C43B5-9139-4716-8205-49769295F4FF

P407

Q36005917-B1EA9760-7856-472F-B1BD-396E241655C5

P433

Q36005917-19762A76-4E16-4867-9C95-F8F30CA020EE

P478

Q36005917-C18042B5-030A-44AE-8C94-F18BFA157F74

P577

Q36005917-3DBAA82C-A5F7-4FA2-BF66-9E5BA6748636

P5875

Q36005917-EC64A994-8B18-4158-935E-091F4DF379F4

P698

Q36005917-EE46CA74-E438-43A8-9D92-D756CE1C05DD

P921

Q36005917-8D0B8529-7840-44CB-9816-AEB5315060A2

Q36005917-B21A3568-B539-450E-9687-88F4C241A1D0

P932

Q36005917-5ABA730A-4460-4806-8324-0CB47BC2995A

P356

AJTMH.2012.11-0467

P1433

American Journal of Tropical Medicine and Hygiene

P1476

Clinical epidemiologic profile ...... asis patients in Bihar, India.

@en

P2093

Alok Ranjan

http://www.w3.org/2001/XMLSchema#string

Chandra S Lal

http://www.w3.org/2001/XMLSchema#string

Dharmendra Singh

http://www.w3.org/2001/XMLSchema#string

Krishna Pandey

http://www.w3.org/2001/XMLSchema#string

Naresh K Sinha

http://www.w3.org/2001/XMLSchema#string

Neena Verma

http://www.w3.org/2001/XMLSchema#string

Niyamat A Siddiqui

http://www.w3.org/2001/XMLSchema#string

Pradeep Das

http://www.w3.org/2001/XMLSchema#string

Rakesh B Verma

http://www.w3.org/2001/XMLSchema#string

Sushmita Das

http://www.w3.org/2001/XMLSchema#string

P2860

The increase in risk factors for leishmaniasis worldwide

Challenges in the diagnosis of post kala-azar dermal leishmaniasis

Post-kala-azar dermal leishmaniasis.

Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas?

Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study.

Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.

Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis.

Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes.

Screening sandflies for natural infection with Leishmania donovani, using a non-radioactive probe based on the total DNA of the parasite.

P304

959-961

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4269/AJTMH.2012.11-0467

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225186596

http://www.w3.org/2001/XMLSchema#string

P698

22665600

http://www.w3.org/2001/XMLSchema#string

P921

visceral leishmaniasis

P932

3366539

http://www.w3.org/2001/XMLSchema#string